Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease: Two Case Reports.

IF 2.9 3区医学 Q2 PHARMACOLOGY & PHARMACY

Journal of Clinical Psychopharmacology Pub Date : 2024-04-19 DOI:10.1097/jcp.0000000000001866

Christiane Först, Sven Ulrich, Gabriela Zurek, Sabine Seifert, Markus Frank, Bernhard Scheidel

引用次数: 0

Abstract

The prevalence of comorbid depression and chronic kidney disease (CKD) is high. The aim of this brief report was to review 2 cases of treatment with tranylcypromine (TCP) in patients with treatment-resistant depression (TRD) and CKD. Tests of the plasma concentration of TCP were included.

查看原文本刊更多论文

慢性肾病抑郁患者的曲安奈德血浆浓度：两个病例报告

抑郁症和慢性肾脏病（CKD）并发症的发病率很高。本简要报告旨在回顾两例使用氨酰西普胺（TCP）治疗耐药抑郁症（TRD）和慢性肾脏病患者的病例。其中包括对 TCP 血浆浓度的检测。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Psychopharmacology 医学-精神病学

CiteScore

4.00

自引率

3.40%

发文量

231

审稿时长

4-8 weeks

期刊介绍： Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.